Real World Data for Competitive Advantage

As advanced analytical methods and large data sets of treatment effectiveness become more readily available, the life science industry is primed to fine-tune its portfolio.  Whether it’s acquiring post-launch data for safety and adherence results, or utilizing evidence to navigate the regulatory and pricing landscape, real world data is a vital tool. 

World Congress’ Real World Data for Competitive Advantage Summit highlights specific application of use cases for commercial optimization in the life sciences.  This two-day educational event features an expert speaking faculty delivering information through in-depth presentations, interactive panel discussions, and intensive case studies, maximizing takeaways for those in attendance.  In addition, ample networking time allows for the forging of mutually beneficial relationships to enhance patient outcomes and technology advancement.

Top Reasons to Attend:

• Learn from specific, innovative real world data use cases and apply insights to help you expand your commercial efforts
• Assess the value of an analytical Center of Excellence and its benefit for internal teams
• Network with senior data professionals on how to collaborate on common challenges such as interoperability of electronic health records
• Gain perspective from alternative sources, such as health systems and regulatory authorities in order to understand partnership potential and expanded acceptance criteria, respectively
• Discuss how real world data fits into value chain development
• Hear a case study from IBM Watson on their revolutionary health IT

Featured Speakers:

Nate Crisel Head of Real World Informatics and Analytics Astellas Pharma, Inc.	Omar Dabbous Head, Health Economics and Outcomes Research Halozyme Therapeutics	Jennifer Dunphy, MBA, MPH Director, Population Health Regal Medical Group
Jesse Fishman Scientific and Real World Data Alliances Lead UCB	Andres Gomez, PhD, MPH Head of Epidemiology, Safety Science and Analytics, Global Pharmacovigilance and Epidemiology Bristol Myers Squibb	James Harnett, PharmD, MS Sr. Director, Analytical Sciences Lead, Real World Data and Analytics, Global Health and Value Pfizer
Usman Iqbal, MD, MPH, MBA Senior Medical Affairs Leader AstraZeneca	Kristijan Kahler, RPh, PhD CoE for Real World Evidence, Head, Outcomes Evidence & Analytics Novartis	Rama Kondru, Ph.D Global Head, Data Sciences and Advanced Analytics, Pharma IT Johnson and Johnson
Steven Labkoff, MD, FACP, FACMI Executive Director, Medical Strategy Purdue Pharma	Julie C. Locklear, PharmD, MBA Vice President & Head, Health Economics & Outcomes Research EMD Serono	Kerry McDermott, MPH Vice President, Public Policy & Communications Center for Medical Interoperability
Kathleen McGroddy Goetz, Ph.D. Vice President, Partnerships & Solutions IBM Watson Health	Igor Rudychev Director, Commercial Analytics, Resource Allocation Team Leader Pfizer Pharmaceuticals	Judy Sewards Vice President, Digital Strategy & Data Innovation Pfizer
Avani Shah, MPH Data Strategy and Acquisition Manager Genentech	Todd A. Townsend, Ph.D. Commissioner’s Fellow United States Food & Drug Administration	Xiaoying Wu, M.D. M.S Director, RWE and IT COE Johnson and Johnson

Call for Papers: Submit Abstract for Presentations

The World Congress Summit on Real World Data for Competitive Advantage is now accepting abstract submissions for 2016!
Deadline is July 29, 2016.
Click here for details.